Indivior Inc, Opioid Bribery Scheme, Virginia 2023

Indivior Inc., a pharmaceutical company with a history of pushing addictive opioid medications, is facing the heat in a federal court. The company’s alleged crime? Bribing doctors to prescribe Suboxone, a popular medication meant to treat opioid addiction, while concealing the risks associated with long-term use. This racketeering scheme has left countless individuals addicted to the very substance they were meant to recover from.

The case against Indivior Inc. has been ongoing since 2019, with prosecutors accusing the company of engaging in a brazen cover-up to increase profits. Suboxone, a buprenorphine-based medication, was marketed as a safe alternative to other opioids, but the company allegedly knew better. By downplaying the risks of long-term use, Indivior Inc. made millions while fueling the opioid epidemic.

Prosecutors have assembled a damning case against the company, with multiple whistleblowers coming forward to expose the scheme. The court has heard testimony from former employees and industry experts, painting a picture of a culture of corruption within Indivior Inc. The company’s actions have been widely condemned, with many calling for stricter regulations on the pharmaceutical industry.

The case against Indivior Inc. is a significant step towards holding the pharmaceutical industry accountable for its role in the opioid crisis. With millions of Americans struggling with addiction, the court’s decision will have far-reaching consequences. Will Indivior Inc. be held responsible for its alleged crimes, or will the company continue to profit from the suffering of others?

MORE FEDERAL CRIME NEWS

Violent Crime

Eley Indicted for Violent Crime, Virginia 2024

Nov 6, 2024

Violent Crime

James Faces Federal Charges in String of High-Profile Crimes

Jul 1, 2009

Violent Crime

TJyon Preston, Murder and Multiple Shootings, Connecticut 2024

Mar 24, 2023

Violent Crime

Lewis, High-Profile Bank Heist, Pennsylvania 2024

Jul 1, 2004